1 / 5

2015 Chimeric Antigen Receptor (CAR) T cell Immunotherapy- C

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells. Complete Report Available at http://www.reportsnreports.com/reports/403154-chimeric-antigen-receptor-car-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2015.html

andreamiller
Download Presentation

2015 Chimeric Antigen Receptor (CAR) T cell Immunotherapy- C

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: July 2015 Single User PDF: US$ 1750 Corporate User PDF: US$ 5000 © ReportsnReports.com / Contact sales@reportsandreports.com

  2. Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015” emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 35+ companies which are active in this field including 14 leading companies with 35 products targeting 20 different antigens and 9 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells. Purchase a Copy of the Report @ http://www.reportsnreports.com/Purchase.aspx?name=403154 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  3. Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 Report Highlights: CAR-T cell Therapy Pipeline scenario Collaborations & partnering deals Current Prominent Research Areas and Key Players Pipeline product profiles CAR-T Technologies and Targeted Antigens Licensing opportunities Market Drivers and Barriers Inquire for this report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=403154 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  4. Scope • Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information • Coverage of global CAR-T cell therapies under development • Competitive landscape of products for key players and related indications • Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation • Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities • Highlights of licensing & collaboration opportunities and funding details • Highlights of latest CAR-T technologies and innovative companies • Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 • Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=403154 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  5. Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015 Reason to buy Pipeline intelligence and complete understanding over therapeutics development of CAR-T cell products to exploit opportunities Explore outcomes of Pre-clinical and clinical studies and Identify prominent therapeutic areas Develop & design strategies to gain competitive advantage by tracking the latest CAR-T technologies and associated innovative companies Track in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Uncovering opportunities in the rapidly growing market, Optimize portfolio, keep updated and make the best decisions for business development Identifying the upcoming leaders and products in the CAR-T cell therapy market in the coming years Understand the CAR-T competitive landscape, plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Complete Report Available @ http://www.reportsnreports.com/reports/403154-chimeric-antigen-receptor-car-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2015.html Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

More Related